| DLCMX | JCRAX | DLCMX / JCRAX | |
| Total Expense Ratio | 1.36 | 1.42 | 96% |
| Annual Report Gross Expense Ratio | 1.43 | 1.57 | 91% |
| Fund Existence | 11 years | 16 years | - |
| Gain YTD | 34.972 | 28.272 | 124% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2000 | 2500 | 80% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 87.6M | 1.06B | 8% |
| Annual Yield % from dividends | 2.11 | 7.43 | 28% |
| Returns for 1 year | 37.87 | 43.60 | 87% |
| Returns for 3 years | 32.99 | 58.10 | 57% |
| Returns for 5 years | 66.06 | 80.30 | 82% |
| Returns for 10 years | 105.03 | 129.54 | 81% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TMNL | 49.51 | 0.06 | +0.11% |
| T. Rowe Price Long Municipal Income ETF | |||
| PCLO | 24.89 | 0.03 | +0.10% |
| Virtus SEIX AAA Private Credit CLO ETF | |||
| JSI | 51.06 | -0.02 | -0.04% |
| Janus Henderson Securitized Income ETF | |||
| IBBQ | 36.11 | -0.18 | -0.50% |
| Invesco Nasdaq Biotechnology ETF | |||
| KOID | 36.08 | -0.81 | -2.20% |
| KraneSharesGlHmndRbtc&PhysclAiIdxETF | |||